How $6 billion generic drug company merger could affect this East Bay city and Roche

The $6 billion merger producing the fifth-largest U.S. generic drug maker could have a big impact on Hayward as well as one of the biggest drugs developed by South San Francisco-based biotech giant Genentech Inc. The merger completed Monday between Hayward's Impax Laboraties Inc. and a partnership known as Amneal Pharmaceuticals LLC likely will change the amount of manufacturing, research and development and administrative work done in the East Bay as the new Amneal Pharmaceuticals Inc. (NASDAQ:…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news